Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Patchett

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
The Journal of Antibiotics|May 1, 1981
Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreusG Albers-Schönberg, H Joshua, M B Lopez, et al.
Journal of Medicinal Chemistry|August 1, 1983
Inhibitors of glycolic acid oxidase. 4-substituted 2,4-dioxobutanoic acid derivativesH W Williams, E Eichler, W C Randall, et al.
The Journal of Endocrinology|February 1, 1997
Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beaglesG J Hickey, T M Jacks, K D Schleim, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Carbohydroxamido-oxazolidines: antibacterial agents that target lipid A biosynthesisM H Chen, M G Steiner, S E de Laszlo, et al.
Journal of Medicinal Chemistry|February 1, 1986
Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computationsE D Thorsett, E E Harris, S D Aster, et al.
Science (New York, N.Y.)|October 11, 1985
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusR S Chang, V J Lotti, R L Monaghan, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|May 29, 1992
Renin inhibitors containing C-termini derived from mercaptoheterocyclesW T Ashton, C L Cantone, L C Meurer, et al.
American Journal of Hypertension|January 1, 1995
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996S D Kivlighn, G J Zingaro, R A Gabel, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
The Journal of Antibiotics|May 1, 1981
Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreusG Albers-Schönberg, H Joshua, M B Lopez, et al.
Journal of Medicinal Chemistry|August 1, 1983
Inhibitors of glycolic acid oxidase. 4-substituted 2,4-dioxobutanoic acid derivativesH W Williams, E Eichler, W C Randall, et al.
The Journal of Endocrinology|February 1, 1997
Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beaglesG J Hickey, T M Jacks, K D Schleim, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Carbohydroxamido-oxazolidines: antibacterial agents that target lipid A biosynthesisM H Chen, M G Steiner, S E de Laszlo, et al.
Journal of Medicinal Chemistry|February 1, 1986
Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computationsE D Thorsett, E E Harris, S D Aster, et al.
Science (New York, N.Y.)|October 11, 1985
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusR S Chang, V J Lotti, R L Monaghan, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|May 29, 1992
Renin inhibitors containing C-termini derived from mercaptoheterocyclesW T Ashton, C L Cantone, L C Meurer, et al.
American Journal of Hypertension|January 1, 1995
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996S D Kivlighn, G J Zingaro, R A Gabel, et al.
Pageof 7